Hyderabad
Raipur
Bhubaneswar
Visakhapatnam
Nagpur
Indore
Chh. SambhajinagarConsult Super-Specialist Doctors at CARE Hospitals
Have you heard about the southeastern pygmy rattlesnake's venom? It gave us a breakthrough in medicine called eptifibatide. It is an antiplatelet drug (prevents blood clotting).
This article covers essential information about eptifibatide, including but not limited to the mechanism of action and dosing guidelines. As a patient, you will benefit from understanding how this medication works, its appropriate use cases, and safety precautions to ensure effective treatment.
A synthetic cyclic heptapeptide, eptifibatide comes from a protein found in the pygmy rattlesnake's venom. Eptifibatide acts as a platelet aggregation inhibitor in the glycoprotein IIb/IIIa class. The medication blocks specific platelet receptors and prevents blood clots from forming in the heart's arteries.
The medication serves these key purposes:
Patients might experience:
Doctors should check for pre-existing bleeding conditions through platelet count, haemoglobin, and serum creatinine tests before treatment. Patients with severe uncontrolled hypertension, recent strokes, or kidney failure should avoid this medication.
Eptifibatide binds to glycoprotein IIb/IIIa receptors on platelets and blocks fibrinogen and other substances from attaching. This action stops platelets from clustering together and forming clots. Platelet function returns to normal gradually when the medication stops as the drug naturally detaches from the receptors. The body eliminates half the medication in about 2.5 hours, which represents its half-life.
Eptifibatide interacts with many medicines. These include but not limited to:
Your doctor will administer these doses for acute coronary syndrome:
Treatment continues 20-24 hours after PCI (angioplasty), but should not exceed 96 hours total. Doctors stop the medication before cardiac surgery so platelet function can recover.
Eptifibatide is an antiplatelet drug that blocks specific platelet receptors in your arteries to prevent clots from forming. The medication's benefits are great for heart patients, especially those who have unstable angina or need procedures like angioplasty.
Eptifibatide can save lives when used properly. Your healthcare team will consider your specific needs, use correct dosing, and watch for complications. This detailed approach helps the drug work better while keeping you safe. Your active role in the treatment process often creates better health outcomes.
Eptifibatide's major side effect is bleeding risk. Clinical trials show that severe bleeding occurred in some patients. Doctors monitor patients closely, especially those who are older, have kidney problems, or are female.
No, Eptifibatide isn't an antibiotic. This medication is a platelet aggregation inhibitor that belongs to the glycoprotein IIb/IIIa class.
The medication acts faster than most. Platelet inhibition happens within 15 minutes after administration. Note that platelet function returns to normal about 4-8 hours after stopping the infusion.
Doctors give Eptifibatide in hospital settings, so missed doses rarely happen. You should contact your doctor right away if the treatment gets interrupted.
Although it's rare, an overdose might lead to chest pain, bradycardia, angioedema, or hypotension. Immediately contact your doctor if you notice these symptoms.
Patients cannot take Eptifibatide if they have:
Medical supervision in hospitals is required for Eptifibatide administration during acute coronary syndrome or percutaneous coronary intervention.
Treatment usually lasts up to 72 hours. PCI patients continue treatment for 20-24 hours after the procedure, with a total duration nowhere near 96 hours.
Doctors must stop the infusion immediately if uncontrollable bleeding occurs. Treatment stops right away for patients who need emergency or urgent cardiac surgery. The medication should stop early enough before semi-elective surgery to let platelet function return to normal.
Eptifibatide doesn't work as a daily long-term medication. Hospitals administer this medication for short periods under medical supervision. Treatment usually continues up to 72 hours for acute coronary syndrome.
Doctors control the timing of this intravenous medication based on your specific condition. They typically start treatment right after diagnosis. The medication coincides with treatment for acute coronary syndrome or during percutaneous coronary intervention.
Avoid:
Your platelet function gradually returns to normal within 4-8 hours as the drug naturally detaches from receptors. Patients with thrombocytopenia usually see their platelet count recover within 1-5 days. Recovery might take up to two weeks.
Research shows no connection between Eptifibatide & weight gain. Weight changes rarely occur because hospitals use this medication only for short periods.
This medication isn't suitable for people with active bleeding within 30 days, severe uncontrolled hypertension, major surgery within 6 weeks, stroke within 30 days, dependency on renal dialysis, or hypersensitivity to the medication.
The kidneys clear about 50% of Eptifibatide in patients with normal renal function. Doctors reduce the infusion dose to 1 mcg/kg/min for patients with kidney impairment. Patients who need dialysis cannot take this medication.
Medical staff in hospitals give Eptifibatide through intravenous injection. Your meal schedule won't change how they administer the treatment. The medical team follows your treatment protocol whatever time you eat.
Patients should avoid:
Let your doctor know about any supplements you keep taking.
Your kidneys need careful monitoring during Eptifibatide treatment because it can interact with kidney problems. The medical team adjusts doses for patients with kidney issues. Your kidneys' function affects how your body processes and removes the medication.